BioSpace News Archive

Business

Actinium Pharmaceuticals to Host Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz

The planned clinical trial will be lead by Dr. Gail Roboz, Director of the Leukemia Program and Professor of Medicine at Weill Cornell Medical College and NewYork-Presbyterian.

November 13, 2017

·

4 min read

Business

RedHill Biopharma Reports 2017 Third Quarter Financial Results

RedHill maintains a debt-free balance sheet with $39.6 million in cash1 at the end of the third quarter of 2017.

November 13, 2017

·

31 min read

Business

Reata Pharmaceuticals Announces Third Quarter 2017 Financial and Operating Results

The Company incurred operating expenses of $24.6 million for the quarter ended September 30, 2017, with research and development accounting for $18.3 million.

November 13, 2017

·

9 min read

FDA

FDA Clears Cianna Medical’s World’s First and Only Wire-Free Radar Breast Tumor Localization System for Long Term Implant Capabilities

The newly acquired FDA clearance means that physicians will no longer be constrained by a maximum implant time, allowing them the flexibility to place SCOUT to mark a biopsy or lumpectomy site.

November 13, 2017

·

4 min read

Drug Development

Melinta Therapeutics Reports First Patient Treated in Phase II Study of Topical Radezolid for Treatment of Acne

The Phase 2 study will enroll approximately 48 individuals with moderate-to-severe facial acne vulgaris .

November 13, 2017

·

7 min read

Business

Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed with DKN-01 and KEYTRUDA (pembrolizumab) in Esophagogastric Cancer Trial

Net loss was $6.8 million for the third quarter of 2017, compared to $7.3 million for the same period in 2016.

November 13, 2017

·

11 min read

First Meeting of Health and Biosciences Economic Strategy Table Identifies Canada With Potential to be Global Economic Powerhouse

Karimah Es Sabar, CEO and Partner, Quark Venture, chaired the first Health and Biosciences Economic Strategy Table meeting in Vancouver, on November 9, 2017.

November 13, 2017

·

3 min read

Drug Development

ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness

The first patient has received the first dose of QR-110 in the Phase 1/2 safety & efficacy clinical trial in children and adults with Leber’s congenital amaurosis 10.

November 13, 2017

·

8 min read

Genetown

Spero Therapeutics Announces Underwriters’ Option Exercise

Spero’s common stock began trading on The Nasdaq Global Select Market on November 2, 2017 under the symbol “SPRO”.

November 13, 2017

·

2 min read

Pharm Country

Creative Peptides Newly Diversified Its Special Antigen Peptides Services

On October 26, 2017, the leading peptides supplier Creative Peptides announced to further diversify its special antigen peptides services after entering this market for nearly a decade.

November 13, 2017

·

1 min read